South Korea · Delayed Price · Currency is KRW MedPacto Statistics
Total Valuation
MedPacto has a market cap or net worth of KRW 93.57 billion. The enterprise value is 59.56 billion.
| Market Cap | 93.57B |
| Enterprise Value | 59.56B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MedPacto has 34.28 million shares outstanding. The number of shares has increased by 0.73% in one year.
| Current Share Class | 34.28M |
| Shares Outstanding | 34.28M |
| Shares Change (YoY) | +0.73% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 11.97% |
| Owned by Institutions (%) | 0.40% |
| Float | 25.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.73 |
| PB Ratio | 2.37 |
| P/TBV Ratio | 2.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.06, with a Debt / Equity ratio of 0.04.
| Current Ratio | 23.06 |
| Quick Ratio | 21.86 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.12 |
| Interest Coverage | -121.43 |
Financial Efficiency
Return on equity (ROE) is -30.76% and return on invested capital (ROIC) is -20.22%.
| Return on Equity (ROE) | -30.76% |
| Return on Assets (ROA) | -19.73% |
| Return on Invested Capital (ROIC) | -20.22% |
| Return on Capital Employed (ROCE) | -38.02% |
| Weighted Average Cost of Capital (WACC) | 5.40% |
| Revenue Per Employee | 89.19M |
| Profits Per Employee | -252.49M |
| Employee Count | 56 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 13.29 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.41% in the last 52 weeks. The beta is 0.21, so MedPacto's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | -40.41% |
| 50-Day Moving Average | 2,716.10 |
| 200-Day Moving Average | 4,625.13 |
| Relative Strength Index (RSI) | 48.30 |
| Average Volume (20 Days) | 104,914 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedPacto had revenue of KRW 4.99 billion and -14.14 billion in losses. Loss per share was -412.76.
| Revenue | 4.99B |
| Gross Profit | 416.80M |
| Operating Income | -15.43B |
| Pretax Income | -14.14B |
| Net Income | -14.14B |
| EBITDA | -14.35B |
| EBIT | -15.43B |
| Loss Per Share | -412.76 |
Balance Sheet
The company has 35.49 billion in cash and 1.48 billion in debt, with a net cash position of 34.01 billion or 992.19 per share.
| Cash & Cash Equivalents | 35.49B |
| Total Debt | 1.48B |
| Net Cash | 34.01B |
| Net Cash Per Share | 992.19 |
| Equity (Book Value) | 39.50B |
| Book Value Per Share | 1,152.31 |
| Working Capital | 37.30B |
Cash Flow
In the last 12 months, operating cash flow was -12.18 billion and capital expenditures -97.72 million, giving a free cash flow of -12.28 billion.
| Operating Cash Flow | -12.18B |
| Capital Expenditures | -97.72M |
| Depreciation & Amortization | 1.08B |
| Net Borrowing | -646.53M |
| Free Cash Flow | -12.28B |
| FCF Per Share | -358.23 |
Margins
Gross margin is 8.34%, with operating and profit margins of -308.89% and -283.09%.
| Gross Margin | 8.34% |
| Operating Margin | -308.89% |
| Pretax Margin | -283.09% |
| Profit Margin | -283.09% |
| EBITDA Margin | -287.24% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MedPacto does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.73% |
| Shareholder Yield | -0.73% |
| Earnings Yield | -15.11% |
| FCF Yield | -13.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 13, 2020. It was a forward split with a ratio of 2.
| Last Split Date | May 13, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
MedPacto has an Altman Z-Score of 30.52 and a Piotroski F-Score of 2.
| Altman Z-Score | 30.52 |
| Piotroski F-Score | 2 |